GLP-1 receptor agonists and tirzepatide gall bladder-related AEs

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2023年 / 1950卷 / 1期
关键词：
D O I：
10.1007/s40278-023-36401-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [1] Is tirzepatide in the surpass lane over GLP-1 receptor agonists for the treatment of diabetes?
    Paneni, Francesco
    Patrono, Carlo
    EUROPEAN HEART JOURNAL, 2021, 42 (41) : 4211 - 4212
  • [2] Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes
    Chuang, Min-Hsiang
    Chen, Jui-Yi
    Wang, Hsien-Yi
    Jiang, Zheng-Hong
    Wu, Vin-Cent
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [3] GLP-1 receptor agonist-related neuropsychiatric AEs
    Reactions Weekly, 2025, 2046 (1) : 7 - 7
  • [4] GLP-1 receptor agonists in NAFLD
    Petit, J. -M.
    Verges, B.
    DIABETES & METABOLISM, 2017, 43 : 2S28 - 2S33
  • [5] Emerging GLP-1 receptor agonists
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (04) : 607 - 618
  • [6] GLP-1 receptor agonists today
    Marre, Michel
    Penfornis, Alfred
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 (03) : 317 - 327
  • [7] The Future of the GLP-1 Receptor Agonists
    Hirsch, Irl B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (15): : 1457 - 1458
  • [8] Positioning on GLP-1 receptor agonists
    Gimenez, Sergio
    Piskorz, Daniel
    Martinez Demaria, Diego
    Nanfara, Silvia
    Lorenzatti, Alberto
    Zapata, Gerardo
    Aguinaga Arrascue, Luis
    Perna, Eduardo
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2021, 50 : 4 - 10
  • [9] GLP-1 receptor agonist-related AEs and potential for misuse
    Reactions Weekly, 2024, 2032 (1) : 4 - 4
  • [10] Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
    Seghieri, Marta
    Christensen, Alexander S.
    Andersen, Andreas
    Solini, Anna
    Knop, Filip K.
    Vilsboll, Tina
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
12345